SEC Form 4 · accession 0001140361-16-047850
CYTRX CORP · CYTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Olivia C Ware
Officer — Chief Commercial Officer
Period of report
Jan 11, 2016
Accepted (ET)
Jan 14, 2016 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000799698
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2,F1 | $2.15 | Jan 11, 2016 | A | 350,000 | A | — | Jan 10, 2026 | CytRx Common Stock | 350,000 | 350,000 | D |
Explanation of responses
- F1The stock option vests monthly for 36 months in equal installments, beginning 11 February 2016, provided Reporting Person remains in continuous employ of issuer.
- F2Initial grant of stock options upon joining CytRx Corporation as Chief Commercial Officer on January 11, 2016.